Prescription and self-reported use of endocrine therapy among Black hormone receptor-positive breast cancer survivors in the Detroit Research on Cancer Survivors cohort
Identifying multilevel factors related to ET use may inform strategies to improve ET uptake and survival among Black women with HR + breast cancer.
Authors
- Ann G. Schwartz (ORCID: https://orcid.org/0000-0002-9525-1157)
- Jennifer Beebe‐Dimmer (ORCID: https://orcid.org/0000-0002-4320-739X)
- Hadeel Assad (ORCID: https://orcid.org/0000-0002-1869-0199)
- Seong Ho Kim (ORCID: https://orcid.org/0000-0002-2371-7042)
- Anna Gottschlich (ORCID: https://orcid.org/0000-0002-3095-2323)
- Christopher Martin (ORCID: https://orcid.org/0000-0002-0029-8885)
- Kristen S. Purrington (ORCID: https://orcid.org/0000-0002-5710-1692)
- Julie J. Ruterbusch (ORCID: https://orcid.org/0000-0001-8089-7409)
- Lauren M. Hamel (ORCID: https://orcid.org/0000-0002-8910-7079)
- Abigail M. Fielder
Institutions
- Wayne State University (US)
- The Barbara Ann Karmanos Cancer Institute (US)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1007/s10549-025-07816-1
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00